Investing.com -- Beiersdorf (ETR: BEIG ) reported a slight beat in first-quarter sales on Tuesday, supported by strong growth in its derma business.

The company’s shares climbed more than 2% in Frankfurt trading.

The German consumer goods group posted organic sales growth of 3.6% to 2.69 billion euros ($3.05 billion), just above the 2.65 billion euros expected by analysts, according to LSEG data.

Sales of Nivea, its core skin and body care brand, rose 2.5% on an organic basis, ahead of the Visible Alpha consensus of 1.5%.

The derma unit saw a more robust increase of 11.4%, driven by solid demand in emerging markets and North America, also beating expectations of 10.9%.

Beiersdorf’s Tesa business posted the strongest beat, seeing sales growth of 10.7%, compared to the Visible Alpha consensus estimate of 3.3%.

On the other hand, sales of its premium skincare brand La Prairie dropped 17.5%, weighed down by challenging market conditions in China.

Beiersdorf reaffirmed its full-year outlook for 2025.

Jefferies analysts said "informal expectations were not high, so 1Q is probably enough to support shares," with the full-year guidance also reiterated.

"BEI is making its own opportunities for growth while others struggle more with weakening categories," they added, reiterating a Buy rating on the stock.